J2505 Injection, pegfilgrastim, 6 mg

Short descriptor: Injection, pegfilgrastim 6mg

⚠ Terminated HCPCS Level II 2026
Terminated Code
J2505 was terminated as of 2021-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open J2505 in the app →

Look up J2505 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J2505 is the HCPCS Level II code for Injection, pegfilgrastim, 6 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Statute.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Statute (indicator 53)
Type of Service
Medical care
Effective Date
2022-01-01
Termination Date
2021-12-31
2026 Maintenance
No change this year

Drug Details

Drug / Substance
pegfilgrastim
Dose / Unit
6 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J2505 with the canonical source and edition:

J2505 — Injection, pegfilgrastim, 6 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J2505

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J2505

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial